Labatec Pharma announces an exclusive licensing agreement signed with AFT Pharmaceuticals, to commercialise MAXIGESIC IV®, in Switzerland
29 March 2023
Would you like to discuss a collaboration or partnership project? Get in touch with us at partnering@labatec.com or connect with us at one of the upcoming events.
For other enquiries, please visit our contact page.